Furry avatar may calm cancer patients during transplant
NCT ID NCT06564233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a friendly animated pet avatar on a tablet, guided by a human-AI team, can help reduce anxiety and improve quality of life for adults undergoing outpatient stem cell transplant for cancer. About 90 participants will be randomly assigned to receive the avatar or standard care. The goal is to see if this digital companion makes the transplant experience less stressful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
care.coach Avatar™ (a virtual pet avatar on a tablet, backed by a human-AI team)
What this could lead to
If it works, this could offer a simple, non-drug way to help patients feel less anxious and more comfortable during stem cell transplant, possibly allowing more people to choose outpatient care.
What could go wrong
This is a small, early-stage trial (90 participants) testing a behavioral tool, not a medical treatment. The avatar may not reduce anxiety significantly, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
Contact